Legal cases alleging everlasting hair loss from the chemotherapy medicine Taxotere continue to develop. Manufacturer Sanofi-Aventis faces over 700 lawsuits in the Taxotere multidistrict litigation (MDL) centralized in Louisiana.
Injured parties allege that the company failed to warn that hair loss with Taxotere, unlike other chemotherapy drugs, can be permanent.
Parker Waichman LLP is a nationwide lawyer representing numerous clients in medicine injury promises. The firm persists to provide free legal consultations to a person with questions about processing a Taxotere Hair Loss Lawsuits.
MDLs are a kind of mass tort founded by the U.S. Judicial -panel on Multidistrict Litigation (JPML). Within an MDL, similar lawsuits are consolidated to 1 courtroom before one judge. Moving cases this way makes complicated litigation better because it gets rid of duplicate finding and overall streamlines proceedings.
Based on the JPML, the Taxotere MDL included 705 lawsuits by Jan. 17, 2017; in a prior update granted on December. 15, 2016, there have been 267 lawsuits in the MDL. These results signify that the litigation is continuing to grow substantially over the holiday season, almost tripling in proportions from mid-December. In Oct 2016, the centralized litigation covered only 33 conditions.